Latest From Biotech Now

Third Annual BIO Convention in China Begins in Beijing

admin-ajax

More than 600 executives from biotech and pharmaceutical companies, along with investment firms from North America, Europe and Asia, are expected this week at BIO’s third annual BIO Convention in China, which kicked off today in Beijing. With over 650 partnering meetings scheduled, the event illustrates just how important China’s biotechnology and life science industry has become, and why building lasting relationships with companies, universities, scientists and government leaders here benefits biotech innovation across the globe. Three keynote Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

Bridging Research to Cures: Summit for R&D Companies

admin-ajax copy

As human and animal health companies struggle to advance medical innovation while managing costs, the outsourcing of research and development functions has become a critical strategy for success. BioResearch Central provides the outsourcing resources needed to accelerate healthcare innovation, to reach patients faster. Born of the legacy of Marion Laboratories and supported by a highly experienced workforce, BioResearch Central companies provide a breadth of services including discovery, toxicology, bioanalytics, clinical trials, regulatory and commercial support. Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Innovation Is… with Doug Doerfler of MaxCyte

Inn-doug115x76

The term innovation is thrown around more often than Peyton Manning’s name during Fantasy Football season. But if any industry can truly capture the essence of innovation, it is the biotech industry. Innovation is inherent in what we do – from curing or treating illnesses that were once considered a death sentence to feeding a growing population to helping to reduce our dependence on foreign oil through the production of biofuels. But what is innovation, Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Washington State Voters Rightly Reject I-522 Food Labeling Proposal

No-on-522-2 copy

False Scare Tactics Fail to Deter Voters As noted on the Washington state general election page, results revealed that 45.16% of voters were in favor of the initiative, while 54.84% of voters rejected the initiative, thus ending one of the most historically expensive battles over a state mandate. If enacted, Initiative 522 would have required the labeling of genetically engineered foods, as defined in the measure, on the packaging of raw agricultural commodities, processed foods, Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , ,

South Carolina Governor Haley at SCBIO Conference

facetoface

BIO’s allied organization in South Carolina will be hosting their third annual conference later this month. SCBIO will be hosting the state’s top chief executive Gov. Nikki Haley as the keynote speaker, along with global biotech financier and analyst G. Steven Burrill. “The Governor played such a critical role in recruiting Nephron and Spirit Pharmaceuticals to the state, her coming signals the significance of this sector, ” said Tom McLean, Chairman of SCBIO. “We also want Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,